Changqing Guo

Dr. Changqing Guo


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2021 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
CGChangqing Guo
Changqing Guo
JHJia Huang
Jia Huang
SJShanshan Jiang
Shanshan Jiang
WRWenwen Rong
Wenwen Rong
YSYaofeng Shen
Yaofeng Shen
QLQingquan Luo
Qingquan Luo

1 September 2013 in Journal of Endodontics
Verified
Journal Article
Closed access
PDF file
TWTian-Tian Wu
Tian-Tian Wu
LLLi-Fen Li
Li-Fen Li
RDRong Du
Rong Du
CGChangqing Guo
Changqing Guo
YZYa-Qin Zhu
Ya-Qin Zhu

1 December 2021 in Translational Lung Cancer Research
Verified
Journal Article
Open access
PDF file
JHJia Huang
Jia Huang
YTYu Tian
Yu Tian
CLChongwu Li
Chongwu Li
YSYaofeng Shen
Yaofeng Shen
HLHecheng Li
Hecheng Li
QLQingquan Luo
Qingquan Luo
Background: Our previous study demonstrated the safety and short-term efficacy of robotic-assisted thoracic surgery (RATS) in clinical N2 (c-N2) stage non-small cell lung cancer (NSCLC) patients. From this, the present study was devised, in which the follow-up time and sample size were both extended to explore the long-term efficacy and potential benefit in survival of RATS compared with lobectomy in c-N2 stage NSCLC patients. Methods: Patients with c-N2 NSCLS were randomly assigned in a 1:1 ratio to accept operation through thoracotomy or RATS. The da Vinci Surgical System (Si/Xi) was applied in the RATS group, while conventional lobectomy with a rib-spreading incision was applied in the posterolateral thoracotomy group. Primary endpoint was defined as disease free survival and overall survival (OS) of all recruited patients. Results: Compared with posterolateral thoracotomy group (N=72), the RATS group (N=76) had a reduced blood loss (P<0.001), decreased drainage duration (P=0.002), and decreased postoperative pain visual analog score (all P<0.001), but increased overall cost (P0.05). Regarding long-term outcome, no difference in disease-free survival (DFS; P=0.925) or OS (P=0.853) was observed between the RATS group and posterolateral thoracotomy group. Subgroup analyses and multivariable Cox regression analyses also found no difference in DFS or OS between the RATS group and posterolateral thoracotomy groups. Conclusions: RATS reduced intraoperative bleeding, drainage duration, postoperative pain, and achieved similar long-term survival outcomes compared with posterolateral thoracotomy in c-N2 stage NSCLC patients. Trial registration: Chinese Clinical Trial Registry ChiCTR-INR-17012777.

1 December 2021 in Translational Lung Cancer Research
Verified
Journal Article
Open access
PDF file
JHJia Huang
Jia Huang
YTYu Tian
Yu Tian
QZQian-Jun Zhou
Qian-Jun Zhou
JNJun-Wei Ning
Jun-Wei Ning
ZGZe-Nan Gu
Ze-Nan Gu
QLQingquan Luo
Qingquan Luo
Comparison of perioperative outcomes of robotic-assisted versus video-assisted thoracoscopic right upper lobectomy in non-small cell lung cancer Jia Huang, Yu Tian, Qian-Jun Zhou, Jun-Wei Ning, Ze-Nan Gu, Pei-Ji Lu, Jian-Tao Li, Hao Lin, Tian-Xiang Chen, Yun-Hai Yang, Min P. Kim, Robert E. Merritt, Marco Ghisalberti, Long Jiang, Qing-Quan Luo

22 May 2015 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
CGChangqing Guo
Changqing Guo
ZZZerui Zhao
Zerui Zhao
SJShanshan Jiang
Shanshan Jiang
YLYongbin Lin
Yongbin Lin
HYHan Yang
Han Yang
HLHao Long
Hao Long

12 November 2019 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
CGChangqing Guo
Changqing Guo
SJShanshan Jiang
Shanshan Jiang
WZWenjie Zhou
Wenjie Zhou
JHJia Huang
Jia Huang
YLYongbin Lin
Yongbin Lin
QLQingquan Luo
Qingquan Luo
Background: Oxidized low density lipoprotein receptor 1 (OLR1), a type II membrane protein, has been identified as receptor for oxidized low-density lipoprotein. The current study firstly provided evidence that OLR1 regulated EMT and thus promoted lung metastases in osteosarcoma (OS). Method: All relevant experiments were conducted according to the manufacturer’s protocols. In vivo tumor xenograft experiments were carried out in 6- to 16-week-old mice, then maintained in our animal facility under pathogen-free conditions in accordance with the Institutional Guidelines and approval by local authorities. For the use of the clinical materials for research purposes, prior patient’s consent and approval from the Institute Research Ethics Committee were obtained. All statistical analyses were performed using IBM SPSS Statistics 22.0 for Windows. Result: Microarrays were adopted to explore the underlying epigenetic mechanisms related to metastasis. 11 genes were identified among total 26,890 differentially expressed genes. After validated in paired primary and metastatic tissues, OLR1 was selected in the current study. The expression levels of OLR1 were tested in 4 widely used cell lines. Cell proliferation, migration and invasion could be enhanced when OLR1 was overexpressed. OLR1 overexpression also triggered G1 to S + G2 phases of cell cycle. Accordingly, cell proliferations, migration and invasion would be reduced when OLR1 was silenced. OLR1-silencing blocked G1 to S + G2 phases of cell cycle. Also, OLR1 silencing effectively suppressed local tumor carcinogenesis and lung metastases in vivo. Moreover, silencing OLR1 repressed the expression of mesenchymal markers (Snail, Twist, and N-cadherin), but induced an epithelial marker (E-cadherin). Conclusion: This study indicated a novel molecular mechanism involving the role of OLR1 in lung metastases of osteosarcoma, strengthened the correlation between OLR1 and lung metastases.